Mayo Clinic Proceedings - Microbiome at the Frontier of Personalized Medicine (December 1, 2017)

One of the premier peer-reviewed clinical journals in general and internal medicine, Mayo Clinic Proceedings is among the most widely read and highly cited scientific publications for physicians, with a circulation of approximately 125,000. Mayo Clinic Proceedings is published by Elsevier and sponsored by Mayo Clinic and the Mayo Foundation for Medical Education and Research. The mission of Mayo Clinic Proceedings is to promote the best interest of patients by advancing the knowledge and professionalism of the physician community. Since 2009 the Journal has offered CME credit for specific articles from both the Mayo Clinic for Concise Review for Clinicians and specially commissioned Symposia articles (comprehensive coverage on one topic).  

Participation in this activity consists of reviewing articles and responding to a short online test. It is estimated that this activity will take approximately one hour per article.  There is no charge for participating in this Journal CME activity.

To receive CME credit, please do the following:

  • Click Take Course
  • Complete quiz and evaluation (There is a required 80% pass rate in order to earn credit, with 1 retake allowed.)
  • Print your Record of Attendance


Questions?  cme@mayo.edu

 

Target Audience

The target audience for Mayo Clinic Proceedings is primarily internal medicine physicians and other clinicians who wish to advance their current knowledge of clinical medicine and who wish to stay abreast of advances in medical research.

Learning Objectives

On completion of this article, you should be able to: (1) give examples of the role of microbiome in drug efficacy as well as adverse events; (2) critique new studies on treatment efficacy in light of new knowledge learned from the role of microbiome; and (3) apply knowledge of the microbiome when explaining therapeutic interventions to patients.

Course summary
Available credit: 
  • 1.00 ABIM
  • 1.00 AMA PRA Category 1 Credit
Course opens: 
12/01/2017
Course expires: 
11/30/2019

Disclosure Summary 

As a Jointly Accredited Provider by ACCME, ACPE, and ANCC, Mayo Clinic College of Medicine and Science must ensure balance, independence, objectivity and scientific rigor in its educational activities. Course Director(s), Planning Committee Members, Faculty, and all others who are in a position to control the content of this educational activity are required to disclose all relevant financial relationships with any commercial interest related to the subject matter of the educational activity. Safeguards against commercial bias have been put in place. Faculty also will disclose any off label and/or investigational use of pharmaceuticals or instruments discussed in their presentation. Disclosure of these relevant financial relationships will be published in activity materials so those participants in the activity may formulate their own judgments regarding the presentation.

Listed below are individuals with control of the content of this program who have disclosed…

No relevant financial relationships:

Planning Committee, Editorial Board Members and Staff
Thomas J. Beckman, M.D.
Timothy B. Curry, M.D., Ph.D.
William L. Lanier, Jr., M.D.
Terry Jopke
Eric L. Matteson, M.D.
Karl A. Nath, M.D.
S. Vincent Rajkumar, M.D.
Kimberly D. Sankey
Nicki Smith
A. Keith Stewart, M.D.
Margaret (Peg) Wentz
Christopher M. Wittich, M.D.

Relevant financial relationships:

Editorial Board:  Michelle Mauermann, M.D. - Consultant - IONIS Pharmaceuticals, Honoraria - Continuum

Off-label drugs:  None.

AUTHORS DISCLOSURE SUMMARY: 

Authors:   Purna C. Kashyap, MBBS; Nicholas Chia, PhD; Heidi Nelson, MD; Eran Segal, PhD; and Eran Elinav, MD, PhD

From the Enteric Neuroscience Program, Department of Gastroenterology and Hepatology  (P.C.K.), and Department of Surgery (N.C., H.N.), Mayo Clinic, Rochester, MN; and Department of  Computer Science (E.S.) and Department of Immunology (E.E.), Weizmann Institute of Science, Rehovot, Israel. 

No relevant financial relationships:
Purna C. Kashyap, MBBS; Nicholas Chia, PhD; Heidi Nelson, MD

Relevant financial relationships:
Potential Competing Interests: Eran Elinav and Eran Segal are consultants to Day Two.

Grant Support: The work was supported in part by grants R01 DK114007 and R03 DK111850 (P.C.K.) from the National Institutes of Health.

Off-label drugs:  None.

Accreditation Statement:


In support of improving patient care, Mayo Clinic College of Medicine and Science is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.

 

Credit Statement(s):

AMA

Mayo Clinic College of Medicine and Science designates this Journal-based CME activity for a maximum of 1.00 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Successful completion of this CME activity enables the participant to earn up to 1 MOC point in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC points.

Other Health Care Professionals

A certificate of attendance will be provided to other health care professionals for requesting credits in accordance with state nursing boards, specialty societies, or other professional associations.

For disclosure information regarding Mayo Clinic School of Continuous Professional Development accreditation review committee member(s), please go here.

Available Credit

  • 1.00 ABIM
  • 1.00 AMA PRA Category 1 Credit

Accreditation Period

Course opens: 
12/01/2017
Course expires: 
11/30/2019
Please login or create an account to take this course.